Last Posted: Dec 18, 2019
- Variation of ApoL1 Testing Practices for Living Kidney Donors.
McIntosh Tristan et al. Progress in transplantation (Aliso Viejo, Calif.) 2019 Dec 1526924819892917 - Frequency of ClinVar Pathogenic Variants in Chronic Kidney Disease Patients Surveyed for Return of Research Results at a Cleveland Public Hospital.
Crawford Dana C et al. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2020 25575-586 - Methods for algorithmic diagnosis of metabolic syndrome.
Vrbaški Dunja et al. Artificial intelligence in medicine 2019 Nov 101101708 - Alport Syndrome in Women and Girls.
Savige Judy et al. Clinical journal of the American Society of Nephrology : CJASN 2016 11(9) 1713-20 - Predicting Risk of Kidney Disease: Is Risk-Based Kidney Care on the Horizon?
SL Tummalapalli et al, JAMA, November 8, 2019 - Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant.
Neugut Y Dana et al. Annals of internal medicine 2019 Oct - How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL.
Averna Maurizio et al. Atherosclerosis. Supplements 2017 Apr 2616-24 - Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease.
Emanuelsson Frida et al. The Journal of clinical endocrinology and metabolism 2018 103(12) 4491-4500 - How Immunotherapy Might Be Used to Treat Heart Failure- Modified immune cells may be trained not just to attack cancer, but any cells in the body that cause disease
G Kolata, NY Times, September 11, 2019 - Practical considerations for APOL1 genotyping in the living kidney donor evaluation.
Mena-Gutierrez Alejandra M et al. Transplantation 2019 Aug
.png)
No hay comentarios:
Publicar un comentario